Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-22T06:23:18.537Z Has data issue: false hasContentIssue false

Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology – ERRATUM

Published online by Cambridge University Press:  22 January 2024

Rights & Permissions [Opens in a new window]

Abstract

Type
Erratum
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press

The publisher apologises that the final three pages of this article were missing in its initial publication. This article has been updated to include the pages.

References

Kaski, JP, Kammeraad, JAE, Blom, NA, et al. Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology. Cardiology in the Young. 2023;33(5):681698. doi: 10.1017/S1047951123000872 CrossRefGoogle Scholar